Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02773524
Title A Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer (INTEGRATEII)
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Australasian Gastro-Intestinal Trials Group

stomach carcinoma

gastroesophageal junction adenocarcinoma

gastric adenocarcinoma



Age Groups: senior | adult
Covered Countries USA | CAN

No variant requirements are available.